Abstract: STUDY DESIGN: In vitro study to develop an intervertebral disc degeneration organ culture model, using coccygeal bovine intervertebral discs (IVDs) and injection of proteolytic enzymes MMP-3, ADAMTS-4, and HTRA1. OBJECTIVE: This study aimed to develop an in vitro model of enzymemediated intervertebral disc degeneration to mimic the clinical outcome in humans for investigation of therapeutic treatment options. SUMMARY OF BACKGROUND DATA: Bovine IVDs are comparable with human IVDs in terms of cell composition and biomechanical behavior. Researchers injected papain and trypsin into them to create an intervertebral disc degeneration model with a degenerated nucleus pulposus (NP) area. They achieved macroscopic cavities as well as a loss of glycosaminoglycans (GAGs). However, none of these enzymes are clinically relevant. METHODS: Bovine IVDs were harvested maintaining the endplates. Active forms of MMP-3, ADAMTS-4, and HTRA1 were injected at a dose of 10 g/mL each. Phosphate-buffered saline was injected as a control. Discs were cultured for 8 days and loaded diurnally (days 1-4 with 0.4 MPa for 16 hr) and left under free swelling condition from days 4 to 8 to avoid expected artifacts because of dehydration of the NP. Outcome parameters included disc height, metabolic cell activity, DNA content, GAG content, total collagen content, relative gene expression, and histological investigation. RESULTS: The mean metabolic cell activity was significantly lower in the NP area of discs injected with ADAMTS-4 than the day 0 control discs. Disc height was decreased after injection with HTRA1 and was significantly correlated with changes in GAG/DNA of the NP tissue. Total collagen content tended to be lower in groups injected with ADAMTS4 and MMP-3. CONCLUSION: MMP-3, ADAMTS-4, and HTRA1 provoked neither visible matrix degradation nor major shifts in gene expression. However, cell activity was significantly reduced and HTRA1 induced loss of disc height that positively correlated with changes in GAG/DNA content. The use of higher doses of these enzymes or a combination thereof may, therefore, be necessary to induce disc degeneration. 
Introduction

1
Low back pain (LBP), a common musculoskeletal disorder [1] [2] [3] with a lifetime-prevalence of up 2 to 84% 4 causes an enormous economic burden due to activity limitation and work absence. 5 
3
Lumbar intervertebral disc degeneration (IDD) is highly associated with non-specific LBP. 6 It 4 is a multi-causal condition due to aging, 7,8 genetic components, 9-11 obesity 12 and carrying out 5 identical work or posture almost all day. 13 Biomechanical studies showed that complex 6 loading like asymmetric compression of the intervertebral disc (IVD) has detrimental 7 effects. 14,15 One major characteristic of IDD is a predominance of catabolic enzymes over the 8 main anabolic components, namely type-II collagen and aggrecan. The proteolytic 9 endopeptidase MMP-3 could be found to induce loss of proteoglycans (PGs) in the aging IVD 10 of mice. 16 Higher levels of MMP-3 were found in human degenerated discs, which suggested 11 that MMP-3 may be involved in IDD. 17 ADAMTS-4, a metalloproteinase, which cleaves 12 aggrecan, 18 is expressed in herniated disc regions, accompanied with a decrease in PGs. 19 
13
Higher degeneration levels could be correlated with higher amount of ADAMTS-4 in NP and 14 AF 20 thus, it plays a major role in IDD. 21 Furthermore, mRNA and protein levels of the serine 15 proteinase HTRA1 were shown to be elevated in patients with severe IDD. 22 It provoked a 16 significant increase in MMP-1,-3, -13 and ADAMTS-4 and a decrease in aggrecan.
17
Current treatment options for IDD in the field of tissue engineering aim to repair or to growth-factors. 26, 27 Before testing them in vivo it is necessary to test them in vitro in an 20 animal organ culture model that exhibits similar cell types, extracellular matrix (ECM) 21 components, biochemical and biomechanical behavior and a degenerated NP area that allows 22 injection of some biomaterial combined with an intact AF. Existing models of IDD using 23 bovine explants generate cavities by injection of papain and trypsin. [28] [29] [30] However, these 24 previously tested enzymes are very general proteases and cleave multiple peptide bindings 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Enzyme-Mediated Intervertebral Disc Degeneration Model 2 and are not very specific to the problem of human IDD. Thus, there is a general lack of 1 knowledge whether more clinical relevant enzymes, such as ADAMTS-4, MMP-3 or HTRA1 2 would cause a degenerative pattern to a disc tissue if injected into a healthy IVD.
3
The aim of this study was to develop an animal organ culture model of enzyme-driven 4 intervertebral disc degeneration that can be used to mimic the clinical outcome of human
5
IDD. Studies were carried out to determine the effects of a single injection of MMP-3,
6
ADAMTS-4 or HTRA1, in bovine coccygeal IVDs cultured for 8 days under diurnal loading.
7
Typical features of IDD observed in this system included decreases in metabolic cell activity, 
Materials and Methods
13
Disc harvest and injection of selected enzymes. , 100ml   25   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64 and standards were prepared in duplicates using saturated NaCl, Chloramin T (Sigma-4 Aldrich) and 4-Dimethylamino-benzaldehyd (DABA) solution (Fluka, Sigma-Aldrich,
5
Switzerland). Absorbance was read at 560nm. All assays were read using a spectramax M5 6 microplate reader (Molecular Devices, Sunnyvale, United States). height and GAG/DNA content. A significance value of p < 0.05 was specified. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 day 0 (p = 0.0433, Figure 2 ). ADAMTS-4 was therefore assumed to be a suitable enzyme to 1 mimic IDD in the described experimental setup. In general, metabolic cell activity was higher 2 for day 0 samples than for day 8 samples (Figure 2 ). This difference was also statistically groups. The values for NP tissue were highest for the PBS control, followed by HTRA1,
13
ADAMTS-4 and MMP-3. The HO-proline content tended to be decreased in ADAMTS-4 and 14 MMP-3 ( Figure 5 ). However, no significant differences were attained between treatment 15 groups, also with respect to GAG/HO-Proline ratio ( Figure 6 ). 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Enzyme-Mediated Intervertebral Disc Degeneration Model 
21
The effect of external loading is an important feature of the study design to consider. biomechanical parameters of bovine disc segment showed that only loading had a significant 7 effect on the MR parameters and biochemical composition in terms of IDD whereas trypsin 8 had a larger effect on the mechanical properties. 43 However, the detrimental role of the 9 loading pattern should be investigated in further studies.
10
In the current study, the metabolic cell activity in NP tissue was significantly lower in discs
11
injected with ADAMTS-4 compared to d0 control. This result suggested that injection of
12
ADAMTS-4 at a concentration of 10µg/ml may lower the cell proliferation and viability in organ culture models using more catabolic proteolytic enzymes like papain and trypsin.
23
Several studies using those enzymes either with or without load revealed more explicit results
24
in terms of detection of macroscopic cavities after injection. Compressive mechanical loading 25   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 even accelerated loss of proteoglycans, water content and mechanical properties in much 1 shorter incubation times (around 24-48h). 28,43,53 A short overview of current studies using 2 trypsin and/or papain (a cysteine protease, Figure 9 ) to simulate IDD is given in Table 2 .
3
Trypsin and papain being non-specific in terms of peptide recognition sites and also being 4 responsible for major GAG loss over a short period of time, however, does not attack cell the macroscopic changes of the investigated three clinically relevant enzymes with the 10 cysteine-dependent proteinase papain there was no real cavity visible using sagittal cuts.
11
Thus, papain produces a highly consistent and reproducible space for injection of biomaterials 12 and seems to act specifically on GAG-rich tissue ( Figure 10 ). exclude uncertainty from activation procedure using mercury-containing compounds, such as 5 4-Amino-Phenyl-Mercuric Acetate (APMA).
6
The ADAMTS (A disintegrin and metalloproteinase with thrombospondin motifs) family In humans, the high temperature requirement (HTRA) serine protease family consists of four 19 members termed HTRA1, -2, -3 and -4. 61 In addition to its involvement in tumor suppression,
20
HTRA1 may also play a role in cartilage, joint and IVD degeneration due to its ability to 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Inhibition of MMPs shown that TNF-α and to an even higher extend IL-1β up-regulates MMP-3, -9 and -13. 65 The 4 third point for regulation is the pro-enzyme activation through the interaction with ECM 5 components. 54 In vivo they are activated by tissue or plasma proteinases. In vitro e.g. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 selected enzymes in future studies. However, we also injected a 100 µg of HTRA1 (~ 100- of loading, we could not detect any striking changes happening to the ECM (data not shown). 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Enzyme-Mediated Intervertebral Disc Degeneration Model Tables   1   Table 1 : Bovine specific primers (Bos taurus) for real time RT-PCR using the SYBR green system. 2
List of
All PCR reactions were run in 2-step protocol (95° for 15s and 57°C for 40s) for 50 cycles. Control group in NP tissue is higher than in all cultured groups, no significant differences 15 amongst the five groups could be found. 
